comparemela.com

Jeanette Bressi News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Dewpoint Therapeutics Partners with Chemify to Apply Groundbreaking Chemistry AI to Radically Accelerate the Discovery of Molecules Targeting Cancer and Neurodegeneration

BOSTON and GLASGOW, Scotland, Sept. 12, 2023 /PRNewswire/ Dewpoint Therapeutics and Chemify today announced a partnership to develop a suite of digitally discovered and automatically synthesized novel molecules on

Glasgow cityUnited kingdomUnited statesLee croninJeanette bressiMarc mosserChemify chemputationScott petersonSwati chatterjeeCorporate developmentCronin digital chemistry laboratoryBusiness developmentNovo nordiskUniversity of glasgowAmeet nathwaniProfessor lee cronin

Dewpoint Therapeutics Granted Second Breakthrough Condensates Platform Technology Patent by US Patent Office

/PRNewswire/ Dewpoint Therapeutics Inc. today announced the U.S. Patent and Trademark Office (USPTO) issued the patent "Methods of Characterizing.

United statesScott petersonJeanette bressiIsaac kleinDewpoint therapeutics incTrademark officeCorporate developmentChief scientific officerDewpoint therapeuticsComputer amp electronicsMedical pharmaceuticalsHealth care amp hospitalsNew products amp servicesPatent law

How Might Biomolecular Condensates Revolutionize Drug Discovery? A Perspective from Dewpoint Therapeutics

/PRNewswire/ A new perspective published in Nature Reviews Drug Discovery examines the potential of biomolecular condensates to transform drug discovery..

United statesDianam mitreaBeatriz ferreira gomesIsaaca kleinMarkm murckoJeanette bressiIsaac kleinMark murckoCommunications pr dewpoint therapeuticsNature reviews drug discoveryDewpoint therapeuticsChief scientific officerDewpoint therapeutics boardScientific advisory board

How Might Biomolecular Condensates Revolutionize Drug Discovery? A Perspective from Dewpoint Therapeutics

/PRNewswire/ A new perspective published in Nature Reviews Drug Discovery examines the potential of biomolecular condensates to transform drug discovery..

United statesDianam mitreaBeatriz ferreira gomesIsaaca kleinMarkm murckoJeanette bressiIsaac kleinMark murckoCommunications pr dewpoint therapeuticsNature reviews drug discoveryDewpoint therapeuticsChief scientific officerDewpoint therapeutics boardScientific advisory boardHealth care amp hospitalsMedical pharmaceuticals

Anthony Hyman, Ph D , pioneer of biomolecular condensates and co-founder of Dewpoint Therapeutics, recognized with two leading science awards

/PRNewswire/ Dewpoint Therapeutics, Inc. today announced biomolecular scientist Anthony Hyman, head of the Max Planck Institute of Molecular Cell Biology.

United statesUnited kingdomTony hymanJeanette bressiMax planck institute of molecular cell biologyBritish royal societyGerman national academy of sciences leopoldinaAmerican national academy of sciencesHope funds for cancer researchAmeet nathwaniMax planck instituteMolecular cell biologyAmerican national academyGerman national academySciences leopoldinaEuropean science prize

vimarsana © 2020. All Rights Reserved.